The GPR179 gene helps the retina, the light sensing tissue at the back of the eye, pass signals needed for vision in dim light. When both copies of this gene do not work properly, that signal can be disrupted, and people may have congenital stationary night blindness, with poor night vision from birth and sometimes nearsightedness, eye movement problems, or crossed eyes. This condition is usually stable over time rather than steadily worsening.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or to regulate processes throughout the body. Some genes provide the directions for producing proteins, which are the active components of cells. Others mainly guide when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
GPR179Gene function
What if the gene works
The GPR179 gene helps the retina pass light signals from photoreceptor cells to ON bipolar cells. This supports normal night vision and the eye’s response when light turns on.
Risk
What if the gene does not work
Variants in the GPR179 gene can disrupt low light signal processing in the retina, causing congenital stationary night blindness. People often have lifelong trouble seeing in dim light, with effects ranging from milder to more marked.
Treatment
What does that mean for your treatment
No GPR179-specific treatment or drug-selection approach is currently established; for people with pathogenic variants in the GPR179 gene, care is supportive and based on symptoms rather than a gene-guided medication choice.
Conditions associated with GPR179
Gene function
What if the gene works
The GPR179 gene helps the retina turn changes in light into clear nerve signals, especially in dim settings. It is most active in ON-bipolar cells, retinal nerve cells that respond when light increases. Understanding how the GPR179 gene helps the retina respond to light gives a practical picture of its role in everyday vision.
This gene supports the step where ON-bipolar cells react after nearby light sensing cells detect light. That helps visual information move through the retina in an orderly way.
Its protein sits at the contact point between retinal cells and helps keep key signaling partners in place. This organized setup lets light messages pass with the right sequence when brightness changes.
GPR179 works with helper proteins that fine tune how quickly the light response starts and settles. This supports smooth visual signaling with well controlled timing.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. Changes like these are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the GPR179 gene can lower protein production, make the protein unstable, or change its shape so it cannot stay in the right place where retinal cells pass signals. Many changes in the GPR179 gene linked to congenital stationary night blindness are loss of function variants, ranging from milder changes with some activity left to more severe variants with little or none. This can change how strongly low light signaling is disrupted.
How variants are linked to conditions
Pathogenic variants in the GPR179 gene cause a form of congenital stationary night blindness called complete congenital stationary night blindness. People with this condition usually have trouble seeing in dim light from early life, and some also have reduced visual sharpness, marked nearsightedness, or involuntary eye movements. In practice, GPR179 gene variants linked to congenital stationary night blindness can support or confirm the diagnosis when the eye findings match.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For GPR179, risk is mainly set by genetics rather than lifestyle. The chance is higher when both parents carry a changed GPR179 gene, especially in families with a history of this inherited night vision condition or when parents are related by blood. There is not enough evidence to say that diet, exercise, or other daily habits change this risk.
Inheritance of GPR179 variants
GPR179 gene variants linked to GPR179-related congenital stationary night blindness are inherited in an autosomal recessive pattern. This means a person usually inherits one nonworking copy of the GPR179 gene from each parent. Parents who each carry one variant are often unaffected, and with each pregnancy there is a 25% chance their child will inherit both variants, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. This pattern explains how GPR179 gene variants are inherited in families.
What does my GPR179 result mean for my family?
For families with a disease-causing GPR179 result, close relatives may also carry the same gene change, even if they do not have symptoms. Brothers and sisters may be affected or may be carriers, and parents are often healthy carriers. Family members may want to learn whether the same result is present in them, especially when night blindness runs in the family.
Genetic information
Genetic testing
How you find out about variants
Variants in the GPR179 gene are found with genetic testing, usually by reading DNA from a blood or saliva sample. A GPR179 genetic test for night blindness often uses a multigene eye panel or exome sequencing and can show whether a variant is likely linked to the condition, benign, or still unclear.
When should I consider getting a genetic test?
Consider genetic testing for the GPR179 gene if someone has had poor night vision since childhood, especially if eye tests suggest an inherited retinal condition. It can also be useful when similar vision problems run in the family or when doctors are checking for congenital stationary night blindness, a lifelong condition that affects seeing in dim light.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. In some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in some people.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies gene and drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strong a drug’s effect is or how the body handles it. This information can support more informed, individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the GPR179 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choices or dosing, so general questions about symptoms, treatment, or medication side effects are best discussed with your doctor.
History
Initially understood only through visible traits, later recognized as tied to a specific gene, GPR179 entered medical genetics through research on inherited night vision problems. In the early 2010s, scientists identified the GPR179 gene as a cause of some cases of congenital stationary night blindness, a condition present from birth that affects seeing in dim light. This finding helped explain why some families had a stable pattern of poor night vision even when the eyes looked otherwise normal on routine exams. From these first observations, research expanded steadily. As more people were studied, GPR179 became part of the growing list of genes used to clarify inherited retinal conditions and support more precise diagnosis.